Klotho Neurosciences
Omaha · Founded 2019
About Klotho Neurosciences
Klotho Neurosciences develops and provide disruptive new therapies to alleviate and/or reverse the progression of cancer and neurodegenerative diseases through the use of cell and gene therapy
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $26.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2025)
- Ticker: otcpink:LEAS
- Website: klothoneuro.com
- Phone: (828) 888-8828
Industries & Categories
Biotechnology, Medical, Neuroscience, Product Research, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/klotho-neurosciences-84365 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.